These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 32257210

  • 1. Hypothesis: bipolar disorder is an Epstein-Barr virus-driven chronic autoimmune disease - implications for immunotherapy.
    Pender MP.
    Clin Transl Immunology; 2020 Apr; 9(4):e1116. PubMed ID: 32257210
    [Abstract] [Full Text] [Related]

  • 2. CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis.
    Pender MP.
    Autoimmune Dis; 2012 Apr; 2012():189096. PubMed ID: 22312480
    [Abstract] [Full Text] [Related]

  • 3. Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection.
    Pender MP.
    Autoimmun Rev; 2009 Jun; 8(7):563-8. PubMed ID: 19254880
    [Abstract] [Full Text] [Related]

  • 4. The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis.
    Pender MP.
    Neuroscientist; 2011 Aug; 17(4):351-67. PubMed ID: 21075971
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy.
    Pender MP, Burrows SR.
    Clin Transl Immunology; 2014 Oct; 3(10):e27. PubMed ID: 25505955
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
    Serafini B, Rosicarelli B, Veroni C, Mazzola GA, Aloisi F.
    J Virol; 2019 Dec 15; 93(24):. PubMed ID: 31578295
    [Abstract] [Full Text] [Related]

  • 7. Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.
    Wang Y, Aïssi-Rothe L, Virion JM, De Carvalho Bittencourt M, Ulas N, Audonnet S, Salmon A, Clement L, Venard V, Jeulin H, Stoltz JF, Decot V, Bensoussan D.
    Cytotherapy; 2014 Jan 15; 16(1):122-34. PubMed ID: 24094498
    [Abstract] [Full Text] [Related]

  • 8. Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.
    Pender MP, Csurhes PA, Burrows JM, Burrows SR.
    Clin Transl Immunology; 2017 Jan 15; 6(1):e126. PubMed ID: 28197337
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr Virus Reactivation-Induced Immunoglobulin Production: Significance on Autoimmunity.
    Nagata K, Hayashi K.
    Microorganisms; 2020 Nov 27; 8(12):. PubMed ID: 33260824
    [Abstract] [Full Text] [Related]

  • 10. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
    Cavalcante P, Galbardi B, Franzi S, Marcuzzo S, Barzago C, Bonanno S, Camera G, Maggi L, Kapetis D, Andreetta F, Biasiucci A, Motta T, Giardina C, Antozzi C, Baggi F, Mantegazza R, Bernasconi P.
    Immunobiology; 2016 Apr 27; 221(4):516-27. PubMed ID: 26723518
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr Virus Lytic Reactivation Activates B Cells Polyclonally and Induces Activation-Induced Cytidine Deaminase Expression: A Mechanism Underlying Autoimmunity and Its Contribution to Graves' Disease.
    Nagata K, Kumata K, Nakayama Y, Satoh Y, Sugihara H, Hara S, Matsushita M, Kuwamoto S, Kato M, Murakami I, Hayashi K.
    Viral Immunol; 2017 Apr 27; 30(3):240-249. PubMed ID: 28333576
    [Abstract] [Full Text] [Related]

  • 12. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.
    Pender MP.
    Trends Immunol; 2003 Nov 27; 24(11):584-8. PubMed ID: 14596882
    [Abstract] [Full Text] [Related]

  • 13. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.
    Latour S, Fischer A.
    Immunol Rev; 2019 Sep 27; 291(1):174-189. PubMed ID: 31402499
    [Abstract] [Full Text] [Related]

  • 14. Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses.
    Choi IK, Wang Z, Ke Q, Hong M, Qian Y, Zhao X, Liu Y, Kim HJ, Ritz J, Cantor H, Rajewsky K, Wucherpfennig KW, Zhang B.
    Proc Natl Acad Sci U S A; 2018 Jan 23; 115(4):E686-E695. PubMed ID: 29311309
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.
    Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, Hastreiter M, Hayes M, Sugden B, Martin L, Moosmann A, Hammerschmidt W.
    Proc Natl Acad Sci U S A; 2016 Oct 18; 113(42):E6467-E6475. PubMed ID: 27698133
    [Abstract] [Full Text] [Related]

  • 16. Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients.
    Petrova M, Muhtarova M, Nikolova M, Magaev S, Taskov H, Nikolovska D, Krastev Z.
    World J Gastroenterol; 2006 Sep 21; 12(35):5711-6. PubMed ID: 17007027
    [Abstract] [Full Text] [Related]

  • 17. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo.
    Murer A, Rühl J, Zbinden A, Capaul R, Hammerschmidt W, Chijioke O, Münz C.
    mBio; 2019 Jan 15; 10(1):. PubMed ID: 30647153
    [Abstract] [Full Text] [Related]

  • 18. Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins.
    van Nierop GP, Mautner J, Mitterreiter JG, Hintzen RQ, Verjans GM.
    Mult Scler; 2016 Mar 15; 22(3):279-91. PubMed ID: 26041797
    [Abstract] [Full Text] [Related]

  • 19. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With SH2D1A/XIAP Hypomorphic Gene Variants.
    Ishimura M, Eguchi K, Shiraishi A, Sonoda M, Azuma Y, Yamamoto H, Imadome KI, Ohga S.
    Front Pediatr; 2019 Mar 15; 7():183. PubMed ID: 31231620
    [Abstract] [Full Text] [Related]

  • 20. Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection.
    Endo R, Yoshioka M, Ebihara T, Ishiguro N, Kikuta H, Kobayashi K.
    Med Hypotheses; 2004 Mar 15; 63(4):582-7. PubMed ID: 15325000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.